A Study to Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment.

Clinical trial NCT02040597 · COMPLETED

Trial details

NCT number: NCT02040597
Sponsor: Chiesi Farmaceutici S.p.A.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2014-01-01
Primary completion: 2015-04-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.